Lei Zuliang

Lei Zuliang discloses dealings in China Health Technology Group Holding Co. Ltd. to HKEX. Between 1 December 2017 and 9 January 2018, the trades on record add up to 2 filings.

Purchases make up the whole of the open-market record (2 purchases, €12k). The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2018 alone, the filings show 2 purchases and no sales.

On 26 February 2018 came the latest disclosure, an open-market purchase in China Health Technology Group Holding Co. Ltd. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.